Spectral Medical Reports Q4 and Fiscal 2025

Spectral Medical Inc. has announced its financial results for the fourth quarter and the full fiscal year 2025. The company, trading under the ticker EDT on the TSX, is a late-stage theranostic firm. While specific financial details are not provided in this announcement, the report typically covers key performance indicators, revenue, profitability, and strategic developments. Investors and stakeholders will be looking for updates on the company's progress in advancing its theranostic technologies and its overall financial health.